S03 Obstructive sleep breathing in toddlers and children younger than 2 years

S03 Obstructive sleep breathing in toddlers and children younger than 2 years
Saturday, April 289:40am-11:10am | 342B

Chair: Ha Trang (France)

9:40am – 9:42am
Introduction
Ha Trang (France)

9:42am – 10:07am
Similiarities and differences in the OSA in toddlers/young children versus the older
Silvia Miano (Switzerland)

10:07am – 10:32am
How to evaluate risk factors and potential co-morbidities of OSA in toddlers/young children?
Helena Larramona (Spain)

10:32am – 10:57am
When and how to treat OSA in toddlers/young children?
Francois Abel (United Kingdom)

10:57am-11:10am
Question and Answer
Ha Trang (France)


Summary of symposium:
The content of this symposium is based upon the ERS statement recently published in Eur Respir J. 2017 Dec 7;50(6). Obstructive sleep-apnea (OSA) is characterized by snoring and/or increased respiratory effort secondary to upper airway resistance and pharyngeal collapsibility associated to dysfunction and /or obstruction of the upper airway during sleep. Toddlers and children younger than 2 years consist a unique subgroup with marked predisposition to upper airway obstruction and not uncommonly with symptoms during wakefulness and thus require age-appropriate diagnostic and treatment steps. As clinical features of OSA in young children differ to those in older ones, symptoms as feeding disorders, cyanotic spells, besides others, are frequently under- and misdiagnosed. In preschool children, hypertrophy of the tonsils is the most important factor which predisposes to OSA, paediatricians are now well aware of daytime and nocturnal symptoms, possible systemic repercussions and signs of severity. However, in young children, a variety of congenital or acquired conditions located from the nose down to the larynx can predispose to OSA. Most general paediatricians are not aware of the possible diagnosis of OSA in syndromic children, worsening their health conditions and quality of life. Thus, the aim of this symposium is to update the knowledge of obstructive breathing disorders in the young child, facilitating the recognition of clinical features of the disorder and to enhance the diagnosis and treatment approach.

Learning Objectives:
Upon Completion of this CME activity, participants should be able to:

1. Determine similiarities and differences of OSA in young children compared to older ones, with regarding clinical symptoms, physical findings, most frequent syndromes associated
2. Evaluate a child at risk (using upper airway endoscopy sleep endoscopy, and sleep studies) and determine potential systemic repercussions (cardiovascular repercussion, cognitive development (memory, special development, language skills), somatic growth)
3. Determine which toddlers/young children should be treated and how: cut-off values for assessment, steps of treatment approach (clinical, role of the surgery of the tonsils, role of tracheostomy, complex surgeries, CPAP)

Target Audience:
Neonatologists, Pediatricians and ENT surgeons involved with sleep disorders, craniofacial malformations, rare diseases